Hepatitis Queensland, Brisbane, 2021.
Information for people with hepatitis, liver disease or liver transplants. With links out to further information.
Taskforce on BBVs, Sexual Health & COVID-19. Sydney, 2021. 21p.
ASHM COVID-19 Taskforce recommendations with respect to the provision of COVID-19 vaccines to people living with blood-borne virus-related chronic liver disease in Australia.
WHO Collaborating Centre for Viral Hepatitis & Doherty Institute, Melbourne, 2021. 17p.
During COVID-19 there were substantial declines in hep & STI screening and hep B/C monitoring.
Nat Drug & Alcohol Research Centre, Sydney, 2021. Reports x 3; 1 infographic
Up-to-date findings from interviews conducted annually from 2000-2020 with a cross-sectional sentinel group of people who regularly inject drugs, recruited from all capital cities of Australia.
Nat Drug & Alcohol Research Centre, Sydney, 2021. 2p
Study explores the short and long-term impacts of the COVID19 pandemic on the experiences of Australians who use illicit drugs.
SA Health, Adelaide, 2016. 2p.
Brief information about how hep D is spread, signs and symptoms, diagnosis and prevention.
Gastroenterology Report (via Oxford Academic), Oxford, 2019. 15p.
Although once thought of as a disappearing disease, hepatitis D is now becoming recognized as a serious worldwide issue. This article reviews the literature from discovery to the current investigational therapies.
The Lancet, London , 2021. 15p.
Decentralisation and integration of HCV care to harm-reduction sites or primary care showed evidence of improved access to testing, linkage to care, and treatment, and task-shifting of care and treatment to non-specialists was associated with similarly high cure rates to care delivered by specialists.
Hepatitis Queensland, Brisbane, 2021. 2p.
Preparing patients for a liver check-up: how to get ready for a FibroScan, what to expect during the examination, tips on keeping healthy and space to record appointments.
Health Vic, Melbourne, 2020. 93p
Information about registration requirements, infection spread and control, procedure specific information, and occupational health and safety procedures for hair, beauty and skin penetration industries.
Health Vic , Melbourne, 2019. 3p
Even though low risk there are some specific health risks. This factsheet outlines general health considerations and includes a chart of cleaning and reprocessing requirements for equipment.
NSW Health, Sydney, 2018. 4p (in 5 languages)
Nail technicians can carry out a variety of different procedures, many of which involve 'skin penetration'. This factsheet provides information about hygiene and cleaning requirements for premises and equipment.
Gastroenterological Society of Australia (GESA), Melbourne, 2021. Video 20mins
Presentation by Miriam Levy about epidemiology and clinical implications.
Hepatitis SA, Adelaide, 2021. 4p. Blog post
How current treatment works, ‘functional cure’, treatment endpoints, reasons to stop treatment, and 5 different treatment strategies.
Journal of Viral Hepatitis Malden, MA John Wiley and Sons 2021. 1p abstract
A nurse‐led HCV program established in a co‐located mental health and addiction service in Melbourne showed a high treatment uptake and cure rate. Abstract only.
Hepatitis NSW, Sydney, 2021. 1p. blog post
Discusses issues for those patients undergoing significant immune suppressive therapy; women who are pregnant and patients with co-infections (e.g. HIV, hep C) or have other chronic health conditions.
Gastroenterological Society of Australia (GESA), Melbourne, 2021. Video 18.13 mins.
Presentation by Professor Alex Thompson, Dept of Gastroenterology, St. Vincent’s Hospital and University of Melbourne.
Gastroenterological Society of Australia (GESA), Melbourne, 2021. Video 15.18 mins
The current guidelines were endorsed a decade ago and are now undergoing an update encompassing new insights into natural history, therapeutic landscape and new models of care.
PLEASE NOTE: THIS RESOURCE IS NO LONGER AVAILABLE - RECALLED FOR UPDATE
Gastroenterological Society of Australia (GESA), Melbourne, 2010. 22p.
Contains natural history and disease progression, screening of high risk groups, diagnosis, treatment, monitoring and management etc.
Research Review, Australia, 2021
A review of the latest important medical research and the local implications. Requires login (free) to view.
Int Journal of Drug Policy, 2021. 1p. abstract.
Social network based interventions (with adequate training) have potential to increase HCV treatment uptake and provide support around stigma.
Clinial Care Options, Reston VA, 2020. PPT slideset.
Review data on improving hepatitis C care in vulnerable populations by increasing access to care and streamlining testing and diagnosis.Requires registration (free) to access.
GESA, Melbourne, 2021. Video 18.14 mins.
Health outcomes, barriers to diagnosis, prevalence, risks, survival time, successful community-led activities (vaccination, networks, testing etc).
Ethnic Communities Council of Qld, Brisbane (undated). Video 3.38 mins
Information about the function of the liver, how hepatitis B & C are transmitted and what to do if diagnosed. Available in multiple language versions.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.